Yıl: 2011 Cilt: 57 Sayı: 3 Sayfa Aralığı: 114 - 118 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients

Öz:
Amaç: Nitrik oksit sentezinin endojen inhibitörü olan asimetrik dimetilargini nin (ADMA) plazma düzeyleri, artmış kardiyovasküler risk, endotelyal dis fonksiyon ve ateroskleroz ile ilişkilidir. Karotid arter intima-media kalınlığı (IMT), koroner arter hastalık gelişimi riski ile yakından ilişkilidir. Biz bu çalış mamızda romatoid artritli hastalarda plazma ADMA düzeylerini belirlemeyi ve bunun karotid IMT ile arasındaki ilişkiyi incelemeyi amaçladık. Gereç ve Yöntem: Araştırmamıza romatoid artrit tanısı konulan 18 Türk hasta(16 kadın, 2 erkek; yaş ortalamaları 49,44±8,88 yıl) ve 18 sağlıklı gönüllü (16 kadın, 2 erkek; yaş ortalamaları 46,28±4,97 yıl) dahil edildi. IMT ölçümü B-mode ultrasonografi ile değerlendirildi. Hasta ve sağlıklı gönüllülerin plazma ADMA düzeyleri ile her iki taraf karotid arter intima-media kalınlıkları ölçülerek iki gru bun ortalamaları karşılaştırıldı. Ayrıca romatoid artritli hastaların ADMA düzeyle rinin karotid arter intima-media kalınlıkları ile olan korelasyonu değerlendirildi.Bulgular: Plazma ADMA düzeyleri hasta grubunda kontrol grubuna göre anlamlı derecede yüksekti. Karotid arter IMT değerleri ise hasta grubunda kontrol grubu na göre yüksek olmasına rağmen bu fark istatistiksel olarak anlamlı değildi. Hasta grubunda ADMA düzeyleri ile karotid IMT değerleri arasında korelasyon yoktu.Sonuç: Bizim sonuçlarımız plazma ADMA düzeylerinin romatoid artritli hasta larda daha yüksek olduğunu göstermiştir. ADMA düzeyleri ile karotid IMT değerleri arasında korelasyon gözlenmemesine rağmen, ADMA seviyeleri endo telyal disfonksiyonun değerlendirilmesinde kullanılabilir. Türk Fiz Tıp Rehab Derg 2011;57:114-8.
Anahtar Kelime:

Konular: Rehabilitasyon

Romatoid artritli hastalarda ADMA düzeyleri ile karotid arter intima-media kalınlığı arasındaki ilişkinin saptanması

Öz:
Objective: Plasma asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, is related to increased cardiovascular risks, endothelial dysfunction and atherosclerosis. Carotid arteryintima-media thickness (IMT) is closely related to the risk of coronary artery disease. We aimed to investigate plasma ADMA levels and itsrelation to carotid IMT in patients with rheumatoid arthritis (RA). Materials and Methods: Eighteen Turkish patients with RA (16 females, mean age: 49.44±8.88 years) and 18 age- and gender-matched healthy controls (16 females, mean age: 46.28±4.97 years) were included in the study. Measurement of IMT was done by B-mode ultrasound. Plasma ADMA levels and carotid IMT of both sides were measured in all patients and healthycontrols, and the means of the two groups were compared. The correlation between ADMA levels and carotid IMT was assessed in patients with RA. Results: Plasma ADMA levels were significantly higher in patientscompared to healthy controls. Although the carotid IMT values wererelatively higher in the patient group than in the control group, thedifference was not statistically significant. There was no significantcorrelation between ADMA levels and carotid IMT values. Conclusion: Our findings support the notion that plasma ADMA levels are elevated in patients with RA. Despite lack of correlation between ADMA levels and IMT in our study, ADMA levels can be used to evaluateendothelial dysfunction. Turk J Phys Med Re hab 2011;57:114-8.
Anahtar Kelime:

Konular: Rehabilitasyon
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Brennan FM, McInnes B. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008;118:3537-45.
  • 2. Naz SM, Symmons DP . Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:871-83.
  • 3. Del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001;44:2737-45.
  • 4. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
  • 5. Gabriel SE. Cardiovascular Morbidity and Mortality in Rheumatoid Arthritis. Am J Med 2008;121:9-14.
  • 6. Dessein PH, Joffe BI, Veller MG, Stevens BA, Tobias M, Reddi K, et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005;32:435-42.
  • 7. Khan F, Galarraga B, Belch JJF. The role of endothelial function and its assessment in rheumatoid arthritis. Nat Rev Rheumatol 2010;6:253-61.
  • 8. Turiel M, Tomasoni L, Sitia S, Cicala S, Gianturco L, Ricci C, et al. Effects of long-term disease-modifying antirheumatic drugs on endothelial function in patients with early rheumatoid arthritis. Cardiovasc Ther 2010;28:53-64.
  • 9. Salliot C, Van Der Heijde D. Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: A systematic literature research. Ann Rheum Dis 2009;68:1100-4.
  • 10. Akhavani MA, Larsen H, Paleolog E. Circulating endothelial progenitor cells as a link between synovial vascularity and cardiovascular mortality in rheumatoid arthritis. Scand J Rheumatol 2007;36:83-90.
  • 11. Vallance P. Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet 2001;358:2096-7.
  • 12. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, et al. Endogenous nitric oxide synthase inhibitor: A novel marker of atherosclerosis. Circulation 1999;99:1141-6.
  • 13. Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Tangphao O, et al. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia. Circulation 1998;98:1842–7.
  • 14. Lundman P, Eriksson MJ, Stühlinger M, Cooke JP, Hamsten A, Tornvall P. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol 2001;38:111-6.
  • 15. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Froöich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 1997;95:2068-74.
  • 16. Surdacki A, Nowicki M, Sandmann J, Tsikas D, Boeger RH, Bode-Boeger SM, et al. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 1999;33:652-8.
  • 17. Stuhlinger MC, Abbasi F, Chu JW, Lamendola C, McLaughlin TL, Cooke JP, et al. Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 2002;287:1420-6.
  • 18. Valkonen VP, Paiva H, Salonen JT, Lakka TA, Lehtimaki T, Laakso J, et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 2001;358:2127-8.
  • 19. Bae SW, Stuhlinger MC, Yoo HS, Yu KH, Park HK, Choi BY, et al. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment. Am J Cardiol 2005;95:729-33.
  • 20. Anthony S, Leiper J, Vallance P . Endogenous production of nitric oxide synthase inhibitors. Vasc Med 2005;10:3-9.
  • 21. Folsom AR, Aleksinc N, Catellier D, Juneja HS, Wu KK. C-reactive protein and incident coronary heart disease in the Atherosclerosis Risk in Communities (AIRC) study. Am Heart J 2002;144:233-8.
  • 22. Sidhu PS, Allan PL. Ultrasound assessment of internal carotid artery stenosis. Clin Radiol 1997;52:654-8.
  • 23. Sydow K, Münzel T. ADMA and oxidative stress. Atheroscler Suppl 2003;4:41-51.
  • 24. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation: Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994;350:9-12.
  • 25. Mallamaci F, Tripepi G, Cutrupi S, Malatino LS, Zoccali C. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD. Kidney Int 2005;67:2330-7.
  • 26. Stafford-Smith M. Heart and kidneys: sharing more than just blood. Curr Opin Anaesthesiol 2007;20:65-9.
  • 27. Del Rincon I, O’Leary DH, Freeman GL, Escalante A. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis 2007;195:354-60.
  • 28. Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how “high grade“ systemic inflammation accelerates cardiovascular risk in rheumatoid arthritis. Circulation 2003;108:2957-63.
  • 29. Del Rincon I, O’Leary DH, Haas RW, Escalante A. Effect of glucocorticoids on the arteries in rheumatoid arthritis. Arthritis Rheum 2004;50:3813-22.
  • 30. Surdacki A, Martens-Lobenhoffer J, Wloch A, Marewicz E, Rakowski T, Wieczorek-Surdacka E, et al. Elevated plasma asymmetric dimethyl-L-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2007;56:809-19.
  • 31. Kiani AN, Mahoney JA, Petri M. Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosus. J Rheumatol 2007;34:1502-5.
  • 32. Turiel M, Atzeni F, Tomasoni L, de Portu S, Delfino L, Bodini BD, et al. Non-invasive assessment of coronary flow reserve and ADMA levels: A case-control study of early rheumatoid arthritis patients. Rheumatology 2009;48:834-9.
APA kARAOĞLAN b, Öztürk G, ÖZDOĞAN V, Cumaoğlu A, ÖZHAN OKTAR S, TAŞ N, ARICIOĞLU A (2011). Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. , 114 - 118.
Chicago kARAOĞLAN bELGİN,Öztürk Gökhan Tuna,ÖZDOĞAN Vildan,Cumaoğlu Ahmet,ÖZHAN OKTAR SUNA,TAŞ Nihal,ARICIOĞLU Aysel Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. (2011): 114 - 118.
MLA kARAOĞLAN bELGİN,Öztürk Gökhan Tuna,ÖZDOĞAN Vildan,Cumaoğlu Ahmet,ÖZHAN OKTAR SUNA,TAŞ Nihal,ARICIOĞLU Aysel Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. , 2011, ss.114 - 118.
AMA kARAOĞLAN b,Öztürk G,ÖZDOĞAN V,Cumaoğlu A,ÖZHAN OKTAR S,TAŞ N,ARICIOĞLU A Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. . 2011; 114 - 118.
Vancouver kARAOĞLAN b,Öztürk G,ÖZDOĞAN V,Cumaoğlu A,ÖZHAN OKTAR S,TAŞ N,ARICIOĞLU A Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. . 2011; 114 - 118.
IEEE kARAOĞLAN b,Öztürk G,ÖZDOĞAN V,Cumaoğlu A,ÖZHAN OKTAR S,TAŞ N,ARICIOĞLU A "Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients." , ss.114 - 118, 2011.
ISNAD kARAOĞLAN, bELGİN vd. "Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients". (2011), 114-118.
APA kARAOĞLAN b, Öztürk G, ÖZDOĞAN V, Cumaoğlu A, ÖZHAN OKTAR S, TAŞ N, ARICIOĞLU A (2011). Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 57(3), 114 - 118.
Chicago kARAOĞLAN bELGİN,Öztürk Gökhan Tuna,ÖZDOĞAN Vildan,Cumaoğlu Ahmet,ÖZHAN OKTAR SUNA,TAŞ Nihal,ARICIOĞLU Aysel Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 57, no.3 (2011): 114 - 118.
MLA kARAOĞLAN bELGİN,Öztürk Gökhan Tuna,ÖZDOĞAN Vildan,Cumaoğlu Ahmet,ÖZHAN OKTAR SUNA,TAŞ Nihal,ARICIOĞLU Aysel Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, vol.57, no.3, 2011, ss.114 - 118.
AMA kARAOĞLAN b,Öztürk G,ÖZDOĞAN V,Cumaoğlu A,ÖZHAN OKTAR S,TAŞ N,ARICIOĞLU A Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2011; 57(3): 114 - 118.
Vancouver kARAOĞLAN b,Öztürk G,ÖZDOĞAN V,Cumaoğlu A,ÖZHAN OKTAR S,TAŞ N,ARICIOĞLU A Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients. Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi. 2011; 57(3): 114 - 118.
IEEE kARAOĞLAN b,Öztürk G,ÖZDOĞAN V,Cumaoğlu A,ÖZHAN OKTAR S,TAŞ N,ARICIOĞLU A "Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients." Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi, 57, ss.114 - 118, 2011.
ISNAD kARAOĞLAN, bELGİN vd. "Investigation of the correlation between ADMA levels and carotid artery intima-media thickness in rheumatoid arthritis patients". Türkiye Fiziksel Tıp ve Rehabilitasyon Dergisi 57/3 (2011), 114-118.